...that leads to neurodegeneration has left drug developers hamstrung, with few good targets. Jean-Pierre Julien, ImStar's... ...active in many tissues. But for whatever reason, in ALS this processing goes awry," said ImStar... ...However, it does not have good drug-like properties and would not have been patentable. ImStar...
...that leads to neurodegeneration has left drug developers hamstrung, with few good targets. Jean-Pierre Julien, ImStar's... ...active in many tissues. But for whatever reason, in ALS this processing goes awry," said ImStar... ...However, it does not have good drug-like properties and would not have been patentable. ImStar...